Filing Details
- Accession Number:
- 0001639691-21-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-20 20:01:52
- Reporting Period:
- 2021-05-18
- Accepted Time:
- 2021-05-20 20:01:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1639691 | Livanova Plc | LIVN | Electromedical & Electrotherapeutic Apparatus (3845) | 981268150 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1798597 | Marco Dolci | 20 Eastbourne Terrace London X0 W26LG | Svp Global Operations, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2021-05-18 | 7,259 | $82.87 | 0 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2021-05-18 | 3,926 | $43.57 | 3,926 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2021-05-18 | 2,907 | $82.98 | 1,019 | No | 4 | F | Direct | |
| Ordinary Shares | Disposition | 2021-05-18 | 1,019 | $83.23 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Appreciation Rights | Disposition | 2021-05-18 | 3,926 | $0.00 | 3,926 | $43.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,777 | No | 4 | M | Direct |
Footnotes
- Represents weighted average selling price. Securities sold through 34 separate sales on the transaction date at prices ranging from $82.31 to $83.21. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer, the full information regarding the number of shares and prices at which the transaction was effected.
- The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability and cost of option exercise.
- On March 30, 2020, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting schedule, the first vesting for which occurred on March 30, 2021. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the LivaNova Incentive Plan and the award agreement.
- This number reflects the number of derivative securities beneficially owned following reported transaction for this specific grant.
Billionaire Hedge Funds
